The next generation of therapies will need to address the full patient experience, including side effects, titration timelines, adherence, persistence, and how quickly patients can reach a therapeutic benefit
Nat Commun 11:3894 Fan X, Wang T, Han M, Gu Y, Sun G, Peng X, Shou Q, Song H, Liu W et al (2022) Dual CEA/CD44 targeting to colorectal cancer cells using nanobody-conjugated hyaluronic acid-modified mesoporous silica nanoparticles with pH-and redox-sensitivity
Second, aged-rat natural cognitive decline used in McCoy 2013 to test Dihexa in a non-pharmacological cognitive-impairment model
8 drips
We keep watch over medicines and devices, and take any necessary action to protect the public promptly if there is a problem
Plasma cholesterol and depressive symptoms in older men Lancet 1993